Artesunate shows potent anti-tumor activity in B-cell lymphoma

BACKGROUND: Although chemo-immunotherapy has led to an improved overall survival for most B-cell lymphoma types, relapsed and refractory disease remains a challenge. The malaria drug artesunate has previously been identified as a growth suppressor in some cancer types and was tested as a new treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Våtsveen, Thea Kristin, Myhre, Marit Renée, Steen, Chloé Beate, Wälchli, Sébastien, Lingjærde, Ole Christian, Bai, Baoyan, Dillard, Pierre, Theodossiou, Theodossis A., Holien, Toril, Sundan, Anders, Inderberg, Else Marit, Smeland, Erlend B., Myklebust, June Helen, Oksvold, Morten P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819282/
https://www.ncbi.nlm.nih.gov/pubmed/29458389
http://dx.doi.org/10.1186/s13045-018-0561-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819282/
https://www.ncbi.nlm.nih.gov/pubmed/29458389
http://dx.doi.org/10.1186/s13045-018-0561-0

Ejemplares similares